A case of scalp angiosarcoma that became chemotherapy－resistant but was controlled for a long time with repeated changes in treatment medication, and a summary of angiosarcoma in our department

Key Points

• The aim is to discuss treatment strategies for chemotherapy-resistant angiosarcoma and analyze clinical outcomes.
• Case report of a 42-year-old female with scalp angiosarcoma.
• Documented treatments included surgical resection, radiation therapy, and multiple chemotherapy regimens.
• Analysis of 24 angiosarcoma cases treated at Iwate Medical University from 2015 to 2025.
• Long-term survival achieved with repeated changes in chemotherapy medications.
• Initial treatments included docetaxel and paclitaxel, leading to skin metastasis.
• Switching to pazopanib resulted in a 200-month survival rate for the patient.
• Survival curves indicated extended survival in patients receiving maintenance chemotherapy.

Structured PICO

Abstract